R.K.M. Protheroe

1.5k total citations
12 papers, 818 citations indexed

About

R.K.M. Protheroe is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, R.K.M. Protheroe has authored 12 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in R.K.M. Protheroe's work include Multiple Myeloma Research and Treatments (11 papers), Peptidase Inhibition and Analysis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). R.K.M. Protheroe is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Peptidase Inhibition and Analysis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). R.K.M. Protheroe collaborates with scholars based in United Kingdom, United States and Italy. R.K.M. Protheroe's co-authors include Laura Chiecchio, Gian Paolo Dagrada, Gareth J. Morgan, David Stockley, Nicholas C.P. Cross, Fiona M. Ross, Christine J. Harrison, Paola Leone, Faith E. Davies and Nicholas J. Dickens and has published in prestigious journals such as Blood, Clinical Cancer Research and Leukemia.

In The Last Decade

R.K.M. Protheroe

12 papers receiving 801 citations

Peers

Countries citing papers authored by R.K.M. Protheroe

Since Specialization

Citations

This map shows the geographic impact of R.K.M. Protheroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.K.M. Protheroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.K.M. Protheroe more than expected).

Fields of papers citing papers by R.K.M. Protheroe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.K.M. Protheroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.K.M. Protheroe. The network helps show where R.K.M. Protheroe may publish in the future.

Co-authorship network of co-authors of R.K.M. Protheroe

This figure shows the co-authorship network connecting the top 25 collaborators of R.K.M. Protheroe. A scholar is included among the top collaborators of R.K.M. Protheroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.K.M. Protheroe. R.K.M. Protheroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance 2010 ·Haematologica ·F. M. Ross, Laura Chiecchio, Gian Paolo Dagrada, R.K.M. Protheroe, David Stockley, Christine J. Harrison, Nicholas C.P. Cross, Alexander J. Szubert, Mark T. Drayson, Gareth J. Morgan, (unknown)	69
2	A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value 2010 ·Blood ·Brian A. Walker, Paola Leone, Laura Chiecchio, Nicholas J. Dickens, Matthew Jenner, Kevin Boyd, David C. Johnson, David González, Gian Paolo Dagrada, R.K.M. Protheroe, Zoë J. Konn, David Stockley, Walter M. Gregory, Faith E. Davies, Fiona M. Ross, Gareth J. Morgan	263
3	Defining High Risk Myeloma Using Co-Segregating FISH Variables; Results of MRC Myeloma IX 2010 ·Blood ·Kevin Boyd, Fiona M. Ross, William Tapper, Laura Chiecchio, Gian Paolo Dagrada, R.K.M. Protheroe, David Stockley, Zoë J. Konn, Walter M. Gregory, Brian A. Walker, Christopher P. Wardell, Faith E. Davies, Gareth J. Morgan	1
4	Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context 2009 ·Haematologica ·Laura Chiecchio, Gian Paolo Dagrada, Ashraf Ibrahim, Elisabet Dachs Cabanas, R.K.M. Protheroe, David Stockley, Kim Orchard, Nicholas C.P. Cross, Christine J. Harrison, F. M. Ross, (unknown)	55
5	Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case 2009 ·Haematologica ·Laura Chiecchio, Gian Paolo Dagrada, R.K.M. Protheroe, David Stockley, Alastair G. Smith, Kim Orchard, Nicholas C.P. Cross, Christine J. Harrison, F. M. Ross, (unknown)	41
6	Frequent upregulation of MYC in plasma cell leukemia 2009 ·Genes Chromosomes and Cancer ·Laura Chiecchio, Gian Paolo Dagrada, Helen E. White, (unknown), R.K.M. Protheroe, Kan Luk Cheung, David Stockley, Kim Orchard, Nicholas C.P. Cross, Christine J. Harrison, Fiona M. Ross	45
7	Gain of 1q21 Does Not Predict for Immediate Progression in MGUS. 2009 ·Blood ·Laura Chiecchio, Gian Paolo Dagrada, Elisabet Dachs Cabanas, R.K.M. Protheroe, David Stockley, Zoë J. Konn, Nicholas C.P. Cross, Christine J. Harrison, Fiona M. Ross	5
8	Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications 2008 ·Clinical Cancer Research ·Paola Leone, Brian A. Walker, Matthew Jenner, Laura Chiecchio, Gian Paolo Dagrada, R.K.M. Protheroe, David C. Johnson, Nicholas J. Dickens, (unknown), Monica Else, David González, Fiona M. Ross, Selina Chen‐Kiang, Faith E. Davies, Gareth J. Morgan	80
9	Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma 2007 ·Blood ·Matthew Jenner, Paola Leone, Brian A. Walker, Fiona M. Ross, David C. Johnson, David González, Laura Chiecchio, Elisabet Dachs Cabanas, Gian Paolo Dagrada, Mathew Nightingale, R.K.M. Protheroe, David Stockley, Monica Else, Nicholas J. Dickens, Nicholas C.P. Cross, Faith E. Davies, Gareth J. Morgan	100
10	Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma 2006 ·Leukemia ·Laura Chiecchio, R.K.M. Protheroe, Ashraf Ibrahim, Kan Luk Cheung, Christina Rudduck, Gian Paolo Dagrada, Elisabet Dachs Cabanas, Torrey Parker, Mathew Nightingale, Ashutosh Wechalekar, Kim Orchard, Christine J. Harrison, Nicholas C.P. Cross, Gareth J. Morgan, F. M. Ross, (unknown)	104
11	Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX and CYLD. 2006 ·Blood ·Matthew Jenner, Paola Leone, Brian A. Walker, David C. Johnson, Laura Chiecchio, Elisabet Dachs Cabanas, Gian Paolo Dagrada, Mathew Nightingale, R.K.M. Protheroe, David Stockley, Monica Else, Fiona M. Ross, Nicholas C.P. Cross, Faith E. Davies, Gareth J. Morgan	1
12	Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma 2005 ·Leukemia ·F. M. Ross, Ashraf Ibrahim, (unknown), (unknown), Laura Chiecchio, R.K.M. Protheroe, P.W. Strike, (unknown), Amy V. Jones, Christine J. Harrison, Gareth J. Morgan, Nicholas C.P. Cross, (unknown)	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact